| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |